Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros











Intervalo de año de publicación
1.
Int J Mol Sci ; 23(16)2022 Aug 13.
Artículo en Inglés | MEDLINE | ID: mdl-36012349

RESUMEN

Cardiovascular diseases (CVDs) are a group of diseases in which the common denominator is the affection of blood vessels, heart tissue, and heart rhythm. The genesis of CVD is complex and multifactorial; therefore, approaches are often based on multidisciplinary management and more than one drug is used to achieve the optimal control of risk factors (dyslipidemia, hypertension, hypertrophy, oxidative stress, endothelial dysfunction, inflammation). In this context, allicin, a sulfur compound naturally derived from garlic, has shown beneficial effects on several cardiovascular risk factors through the modulation of cellular mechanisms and signaling pathways. Effective pharmacological treatments for CVD or its risk factors have not been developed or are unknown in clinical practice. Thus, this work aimed to review the cellular mechanisms through which allicin exerts its therapeutic effects and to show why it could be a therapeutic option for the prevention or treatment of CVD and its risk factors.


Asunto(s)
Enfermedades Cardiovasculares , Ajo , Enfermedades Cardiovasculares/tratamiento farmacológico , Enfermedades Cardiovasculares/prevención & control , Disulfuros/uso terapéutico , Humanos , Ácidos Sulfínicos/farmacología , Ácidos Sulfínicos/uso terapéutico
2.
Int J Mol Sci ; 22(16)2021 Aug 10.
Artículo en Inglés | MEDLINE | ID: mdl-34445305

RESUMEN

Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling. Recent evidence supports that inflammation plays a key role in triggering and maintaining pulmonary vascular remodeling. Recent studies have shown that garlic extract has protective effects in PAH, but the precise role of allicin, a compound derived from garlic, is unknown. Thus, we used allicin to evaluate its effects on inflammation and fibrosis in PAH. Male Wistar rats were divided into three groups: control (CON), monocrotaline (60 mg/kg) (MCT), and MCT plus allicin (16 mg/kg/oral gavage) (MCT + A). Right ventricle (RV) hypertrophy and pulmonary arterial medial wall thickness were determined. IL-1ß, IL-6, TNF-α, NFκB p65, Iκß, TGF-ß, and α-SMA were determined by Western blot analysis. In addition, TNF-α and TGF-ß were determined by immunohistochemistry, and miR-21-5p and mRNA expressions of Cd68, Bmpr2, and Smad5 were determined by RT-qPCR. Results: Allicin prevented increases in vessel wall thickness due to TNF-α, IL-6, IL-1ß, and Cd68 in the lung. In addition, TGF-ß, α-SMA, and fibrosis were lower in the MCT + A group compared with the MCT group. In the RV, allicin prevented increases in TNF-α, IL-6, and TGF-ß. These observations suggest that, through the modulation of proinflammatory and profibrotic markers in the lung and heart, allicin delays the progression of PAH.


Asunto(s)
Antiinflamatorios/uso terapéutico , Disulfuros/uso terapéutico , Hipertensión Pulmonar/tratamiento farmacológico , Ácidos Sulfínicos/uso terapéutico , Animales , Antígenos CD/genética , Antígenos CD/metabolismo , Antígenos de Diferenciación Mielomonocítica/genética , Antígenos de Diferenciación Mielomonocítica/metabolismo , Receptores de Proteínas Morfogenéticas Óseas de Tipo II/genética , Receptores de Proteínas Morfogenéticas Óseas de Tipo II/metabolismo , Citocinas/genética , Citocinas/metabolismo , Fibrosis , Ventrículos Cardíacos/efectos de los fármacos , Ventrículos Cardíacos/metabolismo , Ventrículos Cardíacos/patología , Masculino , FN-kappa B/genética , FN-kappa B/metabolismo , Arteria Pulmonar/efectos de los fármacos , Arteria Pulmonar/metabolismo , Arteria Pulmonar/patología , Ratas , Ratas Wistar , Proteína Smad5/genética , Proteína Smad5/metabolismo
3.
Rev Iberoam Micol ; 25(3): 163-6, 2008 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-18785786

RESUMEN

The natural compound ajoene (4,5,9- trithiadodeca-1,6,11-triene 9-oxide) is capable of controlling infection by Paracoccidioides brasiliensis in experimental models. Swiss mice were inoculated with 5.0 x 10e6 cells of the fungus Paracoccidioides brasiliensis Pb18 by intraperitoneal route and treated with ajoene. In weeks 2, 6, 10 and 13 of treatment, levels of anti-Pb antibodies were measured by the ELISA test and the animals were put down and their lungs, livers and spleens removed for histopathological analysis and determination of the number of viable fungus. The results show that experimental murine paracoccidioidomycosis was well established and that ajoene was capable of controlling the evolution of the disease, as it significantly reduced the levels of antibodies from the 10th week of treatment.


Asunto(s)
Antifúngicos/uso terapéutico , Disulfuros/uso terapéutico , Paracoccidioidomicosis/tratamiento farmacológico , Animales , Modelos Animales de Enfermedad , Masculino , Ratones , Sulfóxidos
4.
Med Mycol ; 46(2): 113-8, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18324489

RESUMEN

Ajoene has been described as an antithrombotic, anti-tumour, antifungal, antiparasitic and antibacterial agent. This study deals with the efficacy of ajoene to treat mice intratracheally infected with Paracoccidioides brasiliensis. The results indicate that ajoene therapy is effective in association with antifungal drugs (sulfametoxazol/trimethoprim), showing a positive additive effect. Ajoene-treated mice developed Th1-type cytokine responses producing higher levels of IFN-gamma and IL-12 when compared to the infected but untreated members of the control group. Antifungal activity of ajoene involves a direct effect on fungi and a protective pro-inflammatory immune response. Reduction of fungal load is additive to chemotherapy and therefore the combined treatment is mostly effective against experimental paracoccidioidomycosis.


Asunto(s)
Antiinfecciosos/uso terapéutico , Disulfuros/uso terapéutico , Ajo/química , Paracoccidioides/efectos de los fármacos , Paracoccidioidomicosis/tratamiento farmacológico , Combinación Trimetoprim y Sulfametoxazol/química , Animales , Antiinfecciosos/química , Antiinfecciosos/farmacología , Productos Biológicos , Terapias Complementarias , Disulfuros/química , Ratones , Ratones Endogámicos BALB C , Pruebas de Sensibilidad Microbiana , Paracoccidioides/inmunología , Paracoccidioides/aislamiento & purificación , Paracoccidioidomicosis/inmunología , Sulfóxidos , Combinación Trimetoprim y Sulfametoxazol/uso terapéutico
5.
Med Mycol ; 44(5): 467-71, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16882614

RESUMEN

The present paper describes 22 cases of chromoblastomycosis (CBM) caused by Cladophialophora carrionii in children and adolescents (2-19 years old). The patients were seen between 1992 and 2004 and all resided in a CBM endemic area in the semi-arid zone of the Falcón state, Venezuela. Twelve of the 22 patients (54.55%) had close relatives who also had CBM and 19 (86.36%) were male. Lesions consisted of erythematous papules with desquamation or squamous plaques (0.12-14.19 cm in diameter), located primarily on the upper limbs (77.27% of patients). Thirteen of the patients were treated with topical 5-fluorouracil (5-FU; 1% cream), seven with topical ajoene (0.5% gel) and two had electrodesiccation and/or fulguration. Two patients who did not respond to 5-FU were treated with oral itraconazole (100 mg/day for 1 month). Complete clinical and mycological remission was achieved in 17/20 (85%) of the patients treated with 5-FC, ajoene and electrodesiccation and/or fulguration. In addition, similar results were obtained with the two patients who received itraconazole therapy. These cases emphasize the importance of early diagnosis in difficult-to-treat mycotic diseases such as CBM. By early intervention we were able to employ topical treatment with a minimum of adverse effects to achieve a high percentage of favorable therapeutic responses. The patients were thus able to avoid the evolution of the chronic, deforming and incapacitation clinical manifestations associated with CBM.


Asunto(s)
Cromoblastomicosis/tratamiento farmacológico , Administración Oral , Administración Tópica , Adolescente , Adulto , Antifúngicos/uso terapéutico , Ascomicetos/aislamiento & purificación , Niño , Preescolar , Cromoblastomicosis/microbiología , Disulfuros/uso terapéutico , Electrocoagulación , Femenino , Fluorouracilo/uso terapéutico , Geles/uso terapéutico , Humanos , Inmunosupresores/uso terapéutico , Itraconazol/uso terapéutico , Masculino , Inducción de Remisión , Sulfóxidos , Resultado del Tratamiento , Venezuela
6.
Rev Iberoam Micol ; 23(2): 75-80, 2006 Jun.
Artículo en Español | MEDLINE | ID: mdl-16854181

RESUMEN

The curative properties of garlic in medicine have been known for a long time. But, it was only in the last three decades when garlic properties were seriously investigated confirming its potential as therapeutic agent. Allicin, ajoene, thiosulfinates and a wide range of other organosulphurate compounds, are known to be the constituents linked to the garlic properties. Regarding the biochemical properties of these compounds, ajoene [(E,Z)-4,5,9 Trithiadodeca 1,6,11 Triene 9-oxide] is stable in water, and it can be obtained by chemical synthesis. There is evidence that some of the garlic constituents exert a wide variety of effects on different biological systems. However, ajoene is the garlic compound related to more biological activities, as showed in in vitro and in vivo systems. Those studies found that ajoene has antithrombotic, anti-tumoral,antifungal, and antiparasitic effects. This study deals with a recently described antifungal property of ajoene, and its potential use in clinical trails to treat several fungal infections.


Asunto(s)
Antifúngicos/uso terapéutico , Dermatomicosis/tratamiento farmacológico , Disulfuros/uso terapéutico , Ajo/química , Animales , Antiinflamatorios no Esteroideos/uso terapéutico , Antifúngicos/aislamiento & purificación , Ensayos Clínicos como Asunto , Disulfuros/aislamiento & purificación , Fibrinolíticos/uso terapéutico , Fluconazol/uso terapéutico , Hongos/efectos de los fármacos , Humanos , Medicina Tradicional , Naftalenos/uso terapéutico , Fitoterapia , Ácidos Sulfínicos/química , Ácidos Sulfínicos/aislamiento & purificación , Ácidos Sulfínicos/uso terapéutico , Sulfóxidos , Terbinafina , Tiña/tratamiento farmacológico
7.
Eur J Pharmacol ; 473(1): 71-8, 2003 Jul 18.
Artículo en Inglés | MEDLINE | ID: mdl-12877940

RESUMEN

Experimental evidences suggest a role of reactive oxygen species in gentamicin-induced nephropathy in rats. Therefore, we investigated if diallyl disulfide, a garlic-derived compound with antioxidant properties, has a renoprotective effect in this experimental model. Four groups of rats were studied: (1) control, (2) gentamicin treated subcutaneously with gentamicin (70 mg/kg/12 h/4 days), (3) diallyl disulfide treated intragastrically with diallyl disulfide (50 mg/kg/24 h/4 days), and (4) gentamicin + diallyl disulfide treated with gentamicin + diallyl disulfide. Gentamicin induced (a) nephrotoxicity, (b) increase in renal oxidative stress, and (c) decrease in the activity of manganese superoxide dismutase, glutathione peroxidase, and glutathione reductase. Diallyl disulfide ameliorated these changes induced by gentamicin. The mechanism by which diallyl disulfide has a renoprotective effect in gentamicin-induced acute renal failure in rats may be related, at least in part, to the amelioration in the oxidative stress and the preservation in the activity of the antioxidant enzymes in kidney.


Asunto(s)
Compuestos Alílicos/uso terapéutico , Antibacterianos/efectos adversos , Antioxidantes/uso terapéutico , Disulfuros/uso terapéutico , Gentamicinas/efectos adversos , Enfermedades Renales/tratamiento farmacológico , Estrés Oxidativo/efectos de los fármacos , Compuestos Alílicos/farmacología , Animales , Antioxidantes/farmacología , Biomarcadores/análisis , Nitrógeno de la Urea Sanguínea , Disulfuros/farmacología , Ajo/química , Riñón/enzimología , Riñón/metabolismo , Riñón/patología , Enfermedades Renales/inducido químicamente , Enfermedades Renales/patología , Masculino , Estrés Oxidativo/fisiología , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo
8.
Med Mycol ; 41(6): 517-20, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14725326

RESUMEN

Ajoene and 5-fluorouracil (5-FU) are compounds that have shown in-vitro activity against Cladophialophora carrionii, an important etiologic agent of chromoblastomycosis. An open comparative trial was conducted to assess safety and effectiveness of topical ajoene and 5-FU in the treatment of localized chromoblastomycosis. Thirty-seven patients with a clinically and mycologically confirmed diagnosis were randomly distributed into two groups allocated to ajoene (0.5% gel; n = 19) or 5-FU (1% cream; n = 18). Topical treatment was applied to localized lesions (< or = 2.5-cm diameter) once a day, with occlusion, for 12-16 weeks. Complete clinical and mycological remission was achieved in 14/19 patients (74%) treated with ajoene and 14/18 patients (78%) treated with 5-FU. All 5-FU-treated patients developed a post-treatment scar at the site of the lesion, while ajoene-treated patients showed only a slight depigmentation of the skin. The differences observed in cure rate between ajoene and 5-FU are not statistically significant. Follow-up of all patients for 4 years revealed no relapses in the ajoene-treated group, while one patient in the 5-FU-treated group had a relapse 6 months after the end of therapy. This trial represents the first clinical use of ajoene in the control of a deep mycosis.


Asunto(s)
Antifúngicos/uso terapéutico , Ascomicetos , Cromoblastomicosis/tratamiento farmacológico , Disulfuros/uso terapéutico , Fluorouracilo/uso terapéutico , Extractos Vegetales/uso terapéutico , Administración Tópica , Adulto , Antifúngicos/administración & dosificación , Antifúngicos/efectos adversos , Ascomicetos/efectos de los fármacos , Ascomicetos/aislamiento & purificación , Cromoblastomicosis/microbiología , Humanos , Masculino , Sulfóxidos
9.
Arzneimittelforschung ; 49(6): 544-7, 1999 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10417874

RESUMEN

Ajoene (CAS 92284-99-6), an organic trisulphur originally isolated from garlic, has an antimycotic activity which has been widely demonstrated both in vitro and in vivo. The objective of this work was to compare the safety and effectiveness of ajoene (0.6%, gel) with terbinafine (CAS 91161-71-6) (1%, cream) for the treatment of tinea corporis and tinea cruris. The patients selected were 60 soldiers with clinical and mycological diagnosis of either dermatophytosis. They were distributed at random in two treatment groups, one treated with ajoene at 0.6% and the other with terbinafine at 1%. All patients were evaluated clinically and mycologically 30 and 60 days after completion of the treatment, which was considered effective when clinical signs and symptoms had disappeared and the mycological cultures were negative. Thirty days after treatment, the percent healing rate was 77 and 75 for the groups treated with ajoene and terbinafine, respectively. Sixty days after treatment, the healing rate 73% and 71% for the groups treated with ajoene and terbinafine, respectively. These results and those obtained in previous studies confirm that ajoene is a new agent for the topic treatment of superficial mycoses, and for the first time show the therapeutic usefulness of an inhibitor of phospholipids biosynthesis in eukaryotes.


Asunto(s)
Antifúngicos/uso terapéutico , Disulfuros/uso terapéutico , Extractos Vegetales/uso terapéutico , Tiña/tratamiento farmacológico , Administración Tópica , Adolescente , Adulto , Antifúngicos/administración & dosificación , Antifúngicos/efectos adversos , Disulfuros/administración & dosificación , Disulfuros/efectos adversos , Geles , Humanos , Naftalenos/uso terapéutico , Extractos Vegetales/administración & dosificación , Extractos Vegetales/efectos adversos , Sulfóxidos , Terbinafina , Tiña/microbiología
10.
Mycoses ; 39(9-10): 393-5, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-9009665

RESUMEN

The present report shows the efficacy of ajoene, a garlic-derived organic trisulphur, for short-term therapy of tinea pedis. The use of ajoene as a 0.4% (w/w) cream resulted in complete clinical and mycological cure in 27 of 34 patients (79%) after 7 days of treatment. The remaining seven patients (21%) achieved complete cure after seven additional days of treatment. All patients were evaluated for recurrence of mycotic infections 90 days after the end of treatment, yielding negative cultures for fungus. These results show that ajoene is an alternative, efficient and low-cost antimycotic drug for short-term therapy of tinea pedis. The fact that ajoene can be easily prepared from an alcoholic extract of garlic may make it suitable for Third World public health care.


Asunto(s)
Antifúngicos/uso terapéutico , Disulfuros/uso terapéutico , Extractos Vegetales/uso terapéutico , Tiña del Pie/tratamiento farmacológico , Administración Tópica , Disulfuros/administración & dosificación , Epidermophyton/aislamiento & purificación , Ajo , Humanos , Personal Militar , Pomadas , Extractos Vegetales/administración & dosificación , Plantas Medicinales , Sulfóxidos , Tiña del Pie/microbiología , Trichophyton/aislamiento & purificación , Venezuela
11.
Dermatol. rev. mex ; 39(1): 22-5, ene.-feb. 1995. tab, ilus
Artículo en Español | LILACS | ID: lil-151317

RESUMEN

Se efectuaron dos estudios doble ciego con el objetivo de comparar los efectos clínicos de diferentes concentraciones de shampoo de ketoconazol vs shampoo de disulfuro de selenio, su acción sobre la persistencia de P. ovale y la incidencia de efectos secundarios. El primer estudio comparó al ketoconasol al 2 por ciento con el disulfuro de selenio al 1 por ciento, y el segundo comparó ketoconazol al 1 por ciento con disulfuro de selenio al 1 por ciento en el tratamiento de la pitiriasis capitis. Los criterios de evaluación fueron la reducción de la descamación y el prurito, así como la negativización de P. ovale en el frotis. Los resultados del primer estudio demostraron mayor eficacia, tanto clínica como micológica, del tratamiento con shampoo de ketoconazol al 2 por ciento. En el segundo estudio ambos grupos mostraron mejoría de los síntomas sin diferencias significativas. Los efectos adversos fueron prurito en un paciente tratado con ketoconazol 2 por ciento y en tres tratados con disulfuro de selenio al 1 por ciento


Asunto(s)
Adolescente , Adulto , Persona de Mediana Edad , Humanos , Masculino , Femenino , Disulfuros/administración & dosificación , Disulfuros/uso terapéutico , Cetoconazol/administración & dosificación , Cetoconazol/uso terapéutico , Pitiriasis/terapia , Selenio/administración & dosificación , Selenio/uso terapéutico
12.
Invest. med. int ; 16(4): 235-9, feb. 1990. tab
Artículo en Español | LILACS | ID: lil-95540

RESUMEN

Al considerara el grave problema estético y social que constituye la caspa, así como su elevada frecuencia entre la población, se decidió estudiar cuatro principios activos anticaspa, contra placebo. Se consideraron los parámetros clínicos más importantes: número de corneocitos, estudio micológico directo, cultivo, cutirreacción, prurito, irritación del cuero cabelludo y caida del cabello. Los resultados mostraron claramente que el disulfuro de selenio solo y en su presentación con acondicionador, fueron las sustancias más eficaces para combatir el problema


Asunto(s)
Humanos , Adolescente , Adulto , Persona de Mediana Edad , Masculino , Femenino , Dermatitis Seborreica/etiología , Dermatitis Seborreica/fisiopatología , Dermatitis Seborreica/terapia , Disulfuros/farmacocinética , Disulfuros/uso terapéutico , Selenio/farmacocinética , Selenio/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA